Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant

Completed · Phase 3

Conditions studied: Kidney Transplantation

In brief

The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.

Key facts

Study ID
NCT00099736
Run by
Novartis Pharmaceuticals
People needed
696
Starts
2003-05-07
Expected to finish
2005-09-19
Last updated by the study team
2017-08-22

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.